<?xml version="1.0" encoding="UTF-8"?>
<p>Given the interest in using HSP90 inhibitors as therapeutics for cancer, a variety of compounds exist (
 <xref rid="R25" ref-type="bibr">
  <italic>25</italic>
 </xref>, 
 <xref rid="R26" ref-type="bibr">
  <italic>26</italic>
 </xref>). For example, GS is an HSP90 inhibitor that differs from GA substantially in chemical structure (compare inset in fig. S4 to that in 
 <xref rid="F3" ref-type="fig">Fig. 3A</xref>) but is thought to have the same mechanism of action (
 <xref rid="R27" ref-type="bibr">
  <italic>27</italic>
 </xref>, 
 <xref rid="R28" ref-type="bibr">
  <italic>28</italic>
 </xref>). The use of GS provides an important test of the capacity of the single-cell analysis to reveal common signature for compounds with common mechanisms.
</p>
